Table 2:

Pre-MRI vascular risk factor exposure relationship with asymptomatic intracranial large artery stenosis (ordinal categories).

		Model 1	Model 2	Model 3
		Odds ratio, 95% confidence intervals
Age (in years) at MRI		1.05, 1.03-1.06s	1.05, 1.03-1.06	1.02, 1.01-1.04
Male sex		1.08, 0.84-1.40	1.18, 0.91-1.53	0.87, 0.67-1.14
Ethnicity
	NH white	Reference group	Reference group	Reference group
	NH black	1.11, 0.75-1.68	1.03, 0.68-1.58	1.00, 0.67-1.451
	Hispanic	1.03, 0.69-1.52	0.89, 0.60-1.34	1.04, 0.72-1.52
High school completed (yes/no)		0.85, 0.62-1.15	0.86, 0.63-1.18	1.12, 0.84-1.49
Visits to PMD during pre MRI follow up period		1.06, 0.55-2.04	1.00, 0.51-1.96	0.77, 0.38-1.57
Hypertension (yes/no) at MRI			1.74, 1.22-2.49
	SBP (per each 5 mmHg)			1.03, 0.99-1.07
	DBP (per each 5 mmHg)			0.98, 0.91-1.06
	Number of antihypertensives at MRI			1.03, 0.88-1.22
	Hypertension duration (in years) at MRI			1.01, 1.001-1.025
Diabetes(yes/no) at MRI			1.60, 1.21-2.13
	Fasting glucose (per each 5 mg/dL)			1.00, 0.98-1.01
	Number of glucose-lowering drugs at MRI			1.64, 1.24-2.15
	Diabetes duration (in years)			0.99, 0.96-1.02
Hypercholesterolemia (yes/no) at MRI			2.03, 1.19-3.46
	LDL (per each 5 mg/dL)			1.01, 1.00-1.03
	HDL (per each 5 mg/dL)			0.96, 0.92-0.99
	Triglycerides (mg/dL)			1.01, 0.99-1.02
	Number of cholesterol-lowering drugs at MRI			1.02, 0.81-1.34
Smoking (yes/no) at MRI			1.21, 0.81-1.82
	Smoking duration (in years)			1.01, 1.00-1.01
	Packs per day (pear each 5)			0.95, 0.76-1.19

Statistical note: Model included all variables with valid beta estimate in each column.

Abbreviations: SD, standard deviation; NH, non-Hispanic; PMD, primary care doctor; SBP, systolic blood pressure; DBP, diastolic blood pressure; mg, milligrams; dL, deciliter; LDL, low density lipoprotein; HDL, high density lipoprotein.